You could do this, or you could do that

What I’d like to write about this month:

• TCAF 2011 / Toronto writeup, with all sorts of great comics-anecdotes
• Visit to Alexander McQueen exhibition at the Met (with side trip down to the Frick)
• TCAF 2010 writeup (boy, did I let that one slide)
• Commentary on The Leopard and The Godfather
• More about seeing Arcadia on Broadway last March
• A really self-indulgent post about menswear
• Ruminations on my trip to Germany next October
• Cute story from last year’s Passover trip to St. Louis

What I will be writing this month:

• 6/4 – Teva – 1050 words
• 6/5 – Johnson & Johnson – 1100 words
• 6/6 – AstraZeneca – 1100 words
• 6/7 – Boehringer-Ingelheim – 400 words
• 6/8 – Bristol-Myers Squibb – 1100 words
• 6/9 – Novo Nordisk – 1000 words
• 6/10 – Bayer Schering – 450 words
• 6/11 – Amgen – 1000 words
• 6/12 – Abbott – 1100 words
• 6/13 – Novartis – 1350 words
• 6/14 – GlaxoSmithKline – 1250 words
• 6/15 – Lilly – 1100 words
• 6/16 – Merck – 1250 words
• 6/17 – Biogen Idec – 400 words
• 6/18 – Merck Serono – 400 words
• 6/20 – Pfizer – 1500 words (I’m giving myself a day off on the 19th)
• 6/21 – Roche/Genentech – 1250 words
• 6/22 – Takeda – 850 words
• 6/23 – Sanofi – 1250 words

Which is to say, it’s time for my Top 20 Pharma / Top 10 Biopharma annual issue! Yes, it’s that regimented, because the Tops issue needs to be wrapped up before July 4th weekend, and I’ll be at the BIO conference June 27-30. Thank gosh I now have an art department to do my layouts.

(Oh, and my associate editor is doing 3 of the writeups, and companies 17-20 and 7-10 in pharma and biopharma don’t get full profile-writeups, in case you’re countng.)

(Plus I’ll need to transcribe about 3 hours of interviews for a series of Q&A sidebars. What do you think I’ll be doing on those days with the 400-word writeups?)